These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37264870)

  • 1. [Not Available].
    Kårhus ML; Ellegaard AM; Rix I; Knop FK
    Ugeskr Laeger; 2023 May; 185(20):. PubMed ID: 37264870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol for a randomised, double-blinded, placebo-controlled, double-dummy 6-week clinical trial comparing the treatment effects of the glucagon-like peptide 1 receptor agonist liraglutide versus the bile acid sequestrant colesevelam on bile acid malabsorption.
    Kårhus ML; Brønden A; Lyng Forman J; Haaber A; Vilsbøll T; Sonne DP; Knop FKK
    BMJ Open; 2021 Feb; 11(2):e044711. PubMed ID: 33558360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SeHCAT [tauroselcholic (selenium-75) acid] for the investigation of bile acid malabsorption and measurement of bile acid pool loss: a systematic review and cost-effectiveness analysis.
    Riemsma R; Al M; Corro Ramos I; Deshpande SN; Armstrong N; Lee YC; Ryder S; Noake C; Krol M; Oppe M; Kleijnen J; Severens H
    Health Technol Assess; 2013 Dec; 17(61):1-236. PubMed ID: 24351663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: a randomised, double-blind, active-comparator, non-inferiority clinical trial.
    Kårhus ML; Brønden A; Forman JL; Haaber A; Knudsen E; Langholz E; Dragsted LO; Hansen SH; Krakauer M; Vilsbøll T; Sonne DP; Knop FK
    Lancet Gastroenterol Hepatol; 2022 Oct; 7(10):922-931. PubMed ID: 35868334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating bile acid diarrhoea with liraglutide.
    Walters JRF
    Lancet Gastroenterol Hepatol; 2022 Oct; 7(10):897-899. PubMed ID: 35868333
    [No Abstract]   [Full Text] [Related]  

  • 6. Obeticholic acid for severe bile acid diarrhea with intestinal failure: A case report and review of the literature.
    Hvas CL; Ott P; Paine P; Lal S; Jørgensen SP; Dahlerup JF
    World J Gastroenterol; 2018 Jun; 24(21):2320-2326. PubMed ID: 29881241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The response of patients with bile acid diarrhoea to the farnesoid X receptor agonist obeticholic acid.
    Walters JR; Johnston IM; Nolan JD; Vassie C; Pruzanski ME; Shapiro DA
    Aliment Pharmacol Ther; 2015 Jan; 41(1):54-64. PubMed ID: 25329562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liraglutide versus colesevelam for treating bile acid diarrhoea.
    Zhang F; Ge C
    Lancet Gastroenterol Hepatol; 2022 Dec; 7(12):1075. PubMed ID: 36370737
    [No Abstract]   [Full Text] [Related]  

  • 9. Liraglutide versus colesevelam for treating bile acid diarrhoea - Authors' reply.
    Kårhus ML; Knop FK
    Lancet Gastroenterol Hepatol; 2022 Dec; 7(12):1075-1076. PubMed ID: 36370738
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term effect of medical treatment of diarrhoea in 377 patients with SeHCAT scan diagnosed bile acid malabsorption from 2003 to 2016; a retrospective study.
    Damsgaard B; Dalby HR; Krogh K; Jørgensen SMD; Arveschough AK; Agnholt J; Dahlerup JF; Jørgensen SP
    Aliment Pharmacol Ther; 2018 Apr; 47(7):951-957. PubMed ID: 29368342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and predictive factors for positive
    Murray IA; Murray LK; Woolson KL; Sherfi H; Dixon I; Palmer J; Sulkin T
    Scand J Gastroenterol; 2017; 52(6-7):698-703. PubMed ID: 28276822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile acid malabsorption in patients with chronic diarrhoea.
    Eusufzai S
    Scand J Gastroenterol; 1993 Oct; 28(10):865-8. PubMed ID: 8266014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remission of Bile Acid Malabsorption Symptoms Following Treatment With the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide.
    Kårhus ML; Brønden A; Røder ME; Leotta S; Sonne DP; Knop FK
    Gastroenterology; 2019 Aug; 157(2):569-571. PubMed ID: 30965026
    [No Abstract]   [Full Text] [Related]  

  • 14. Biliary effects of liraglutide and sitagliptin, a 12-week randomized placebo-controlled trial in type 2 diabetes patients.
    Smits MM; Tonneijck L; Muskiet MH; Hoekstra T; Kramer MH; Diamant M; Nieuwdorp M; Groen AK; Cahen DL; van Raalte DH
    Diabetes Obes Metab; 2016 Dec; 18(12):1217-1225. PubMed ID: 27451030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of bile-acid binding agents in post-vagotomy diarrhoea.
    Taylor TV; Lambert ME; Torrance HB
    Lancet; 1978 Mar; 1(8065):635-6. PubMed ID: 76170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case for screening real-world data for collateral drug benefits: Glucagon-like peptide 1 receptor agonists and bile acid diarrhea.
    Rahbek MT; Lund LC; Hallas J
    Pharmacoepidemiol Drug Saf; 2024 Jan; 33(1):e5673. PubMed ID: 37559355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile acid malabsorption investigated by selenium-75-homocholic acid taurine ((75)SeHCAT) scans: causes and treatment responses to cholestyramine in 298 patients with chronic watery diarrhoea.
    Borghede MK; Schlütter JM; Agnholt JS; Christensen LA; Gormsen LC; Dahlerup JF
    Eur J Intern Med; 2011 Dec; 22(6):e137-40. PubMed ID: 22075299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised clinical trial: significant biochemical and colonic transit effects of the farnesoid X receptor agonist tropifexor in patients with primary bile acid diarrhoea.
    Camilleri M; Nord SL; Burton D; Oduyebo I; Zhang Y; Chen J; Im K; Bhad P; Badman MK; Sanders DS; Walters JRF
    Aliment Pharmacol Ther; 2020 Sep; 52(5):808-820. PubMed ID: 32702169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cause and treatment of postvagotomy diarrhoea.
    Condon JR; Robinson V; Suleman MI; Fan VS; McKeown MD
    Br J Surg; 1975 Apr; 62(4):309-12. PubMed ID: 1131510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The postvagotomy syndrome (author's transl)].
    Stremmel W
    Zentralbl Chir; 1977; 102(4):231-5. PubMed ID: 848198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.